Corrections: (The Lancet Respiratory Medicine (2017) 5 (3) (180–190) (S2213260017300462) (10.1016/S2213-2600(17)30046-2));Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial

The Lancet Respiratory Medicine

Volumn 5, Issue 3, 2017, Pages 180-190

  Asfar, Pierre ^a   Schortgen, Frédérique ^c   Boisramé Helms, Julie ^d   Charpentier, Julien ^f   Guérot, Emmanuel ^g   Megarbane, Bruno ^h   Grimaldi, David ⁱ   Grelon, Fabien ^j   Anguel, Nadia ^k   Lasocki, Sigismond ^b   Henry Lagarrigue, Matthieu ^j   Gonzalez, Frédéric ^h   Legay, François ^j   Guitton, Christophe ^l   Schenck, Maleka ^e   Doise, Jean Marc ^j   Devaquet, Jérôme ^m   Van Der Linden, Thierry ⁿ   Chatellier, Delphine ^o   Rigaud, Jean Philippe ^j   Dellamonica, Jean ^p   Tamion, Fabienne ^q   Meziani, Ferhat ^d   Mercat, Alain ^a   Dreyfuss, Didier ^r   Seegers, Valérie ^s   Radermacher, Peter ^t   more..

^a Universitéd'Angers Facultéde Santé   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL CIVIL   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f Centre Hospitalo Universitaire Le Kremlin Bicêtre ^*  (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

ⁱ Centre hospitalier Henri Mignot   (France)

^j CENTRE HOSPITALIER   (France)

^k BICÊTRE HOSPITAL   (France)

^l NANTES UNIVERSITY HOSPITAL   (France)

^m FOCH HOSPITAL   (France)

ⁿ Centre Hospitalier Saint Philibert GHICL   (France)

^o Centre Hospitalo Universitaire   (France)

^p UNIVERSITY HOSPITAL OF NICE   (France)

^q ROUEN UNIVERSITY HOSPITAL   (France)

^r HÔPITAL LOUIS MOURIER   (France)

^s NONE   (France)

^t Institut für anesthesiologische Pathophysiologie und Verfahrensentwicklung   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FLUID RESUSCITATION; FRANCE; HIGH RISK PATIENT; HUMAN; HYPEROXIA; INSPIRATORY OXYGEN CONCENTRATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OXYGEN CONCENTRATION; OXYGEN SATURATION; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; WEAKNESS; CLINICAL TRIAL; COMPLICATION; ETIOLOGY; FLUID THERAPY; INTENTION TO TREAT ANALYSIS; MIDDLE AGED; PROCEDURES; RESUSCITATION; TREATMENT OUTCOME;

AGED; FEMALE; FLUID THERAPY; FRANCE; HUMANS; HYPEROXIA; INTENSIVE CARE UNITS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RESUSCITATION; SALINE SOLUTION, HYPERTONIC; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 85012878798     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30269-2     Document Type: Erratum

References (35)

1. 1 Vincent, JL, De Backer, D, Circulatory shock. N Engl J Med 369 (2013), 1726–1734.
2. 2 Dellinger, RP, Levy, MM, Rhodes, A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39 (2013), 165–228.
3. 3 Hafner, S, Beloncle, F, Koch, A, Radermacher, P, Asfar, P, Hyperoxia in intensive care, emergency, and peri-operative medicine: Dr. Jekyll or Mr. Hyde? A 2015 update. Ann Intensive Care, 5, 2015, 42.
4. 4 Knighton, DR, Halliday, B, Hunt, TK, Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg 119 (1984), 199–204.
5. 5 Yang, W, Liu, Y, Zhang, Y, Zhao, QH, He, SF, Effect of intra-operative high inspired oxygen fraction on surgical site infection: a meta-analysis of randomized controlled trials. J Hosp Infect 93 (2016), 329–338.
6. 6 Bitterman, H, Bench-to-bedside review: oxygen as a drug. Crit Care, 13, 2009, 205.
7. 7 Helmerhorst, HJ, Arts, DL, Schultz, MJ, et al. Metrics of arterial hyperoxia and associated outcomes in critical care. Crit Care Med 45 (2017), 187–195.
8. 8 Eastwood, G, Bellomo, R, Bailey, M, et al. Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med 38 (2012), 91–98.
9. 9 Myburgh, JA, Mythen, MG, Resuscitation fluids. N Engl J Med 369 (2013), 1243–1251.
10. 10 Oliveira, RP, Velasco, I, Soriano, FG, Friedman, G, Clinical review: hypertonic saline resuscitation in sepsis. Crit Care 6 (2002), 418–423.
11. 11 Fang, ZX, Li, YF, Zhou, XQ, et al. Effects of resuscitation with crystalloid fluids on cardiac function in patients with severe sepsis. BMC Infect Dis, 8, 2008, 50.
12. 12 van Haren, FM, Sleigh, J, Boerma, EC, et al. Hypertonic fluid administration in patients with septic shock: a prospective randomized controlled pilot study. Shock 37 (2012), 268–275.
13. 13 Bihari, S, Laffey, JG, Bersten, AD, The ten studies that should be done in ARDS. Intensive Care Med 42 (2016), 783–786.
14. 14 Bone, RC, Balk, RA, Cerra, FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992), 1644–1655.
15. 15 Ranieri, VM, Rubenfeld, GD, Thompson, BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307 (2012), 2526–2533.
16. 16 Asfar, P, Meziani, F, Hamel, JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 370 (2014), 1583–1593.
17. 17 Kapanci, Y, Tosco, R, Eggermann, J, Gould, VE, Oxygen pneumonitis in man. Light- and electron-microscopic morphometric studies. Chest 62 (1972), 162–169.
18. 18 Marko, NF, Hyperosmolar therapy for intracranial hypertension: time to dispel antiquated myths. Am J Respir Crit Care Med 185 (2012), 467–468.
19. 19 Vincent, JL, Moreno, R, Takala, J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22 (1996), 707–710.
20. 20 Heyland, DK, Muscedere, J, Drover, J, Jiang, X, Day, AG, Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials. Crit Care, 15, 2011, R98.
21. 21 Murray, JF, Matthay, MA, Luce, JM, Flick, MR, An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138 (1988), 720–723.
22. 22 Moreno, RP, Metnitz, PG, Almeida, E, et al. SAPS 3—from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 31 (2005), 1345–1355.
23. 23 Kilgannon, JH, Jones, AE, Shapiro, NI, et al. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA 303 (2010), 2165–2171.
24. 24 Bellomo, R, Bailey, M, Eastwood, GM, et al. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care, 15, 2011, R90.
25. 25 Damiani, E, Adrario, E, Girardis, M, et al. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care, 18, 2014, 711.
26. 26 Helmerhorst, HJ, Roos-Blom, MJ, van Westerloo, DJ, de Jonge, E, Association between arterial hyperoxia and outcome in subsets of critical illness: a systematic review, meta-analysis, and meta-regression of cohort studies. Crit Care Med 43 (2015), 1508–1519.
27. 27 Girardis, M, Busani, S, Damiani, E, et al. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA 316 (2016), 1583–1589.
28. 28 Stolmeijer, R, ter Maaten, JC, Zijlstra, JG, Ligtenberg, JJ, Oxygen therapy for sepsis patients in the emergency department: a little less?. Eur J Emerg Med 21 (2014), 233–235.
29. 29 Kress, JP, Hall, JB, ICU-acquired weakness and recovery from critical illness. N Engl J Med 370 (2014), 1626–1635.
30. 2: a mathematical description. Intensive Care Med 32 (2006), 1494–1497.
31. 31 Lightner, D, Park, Y, Singlet oxygen reactivity of bilirubin and related tetrapyrroles. Experientia 34 (1978), 555–556.
32. 32 Angus, DC, Mira, JP, Vincent, JL, Improving clinical trials in the critically ill. Crit Care Med 38 (2010), 527–532.
33. 33 Hannemann, L, Reinhart, K, Korell, R, Spies, C, Bredle, DL, Hypertonic saline in stabilized hyperdynamic sepsis. Shock 5 (1996), 130–134.
34. 34 Muller, L, Lefrant, JY, Jaber, S, et al. Short term effects of hypertonic saline during severe sepsis and septic shock. Ann Fr Anesth Reanim 23 (2004), 575–580.
35. 35 van Haren, FM, Sleigh, J, Cursons, R, La Pine, M, Pickkers, P, van der Hoeven, JG, The effects of hypertonic fluid administration on the gene expression of inflammatory mediators in circulating leucocytes in patients with septic shock: a preliminary study. Ann Intensive Care, 1, 2012, 44.